Department of Neurology, Medical School, University of Crete, Heraklion, Crete, Greece.
Neurochem Int. 2012 Sep;61(4):470-81. doi: 10.1016/j.neuint.2012.05.020. Epub 2012 May 30.
Mammalian glutamate dehydrogenase (GDH) is a housekeeping mitochondrial enzyme (hGDH1 in the human) that catalyses the reversible inter-conversion of glutamate to α-ketoglutarate and ammonia, thus interconnecting amino acid and carbohydrate metabolism. It displays an energy sensing mechanism, which permits enzyme activation under low cellular energy states. As GDH is at the crossroads of important metabolic pathways, a tight control of its activity is essential. Indeed, to fulfill its role in metabolism and cellular energetics, mammalian GDH has evolved into a highly regulated enzyme subject to allosteric modulation by diverse compounds. The recent emergence (<23 million years ago) in apes and humans of a hGDH2 isoenzyme with distinct regulatory properties, as well as, the detection of gain-of-function variants in hGDH1 and hGDH2 that affect the nervous system, have introduced additional complexities. The properties of the two highly homologous human GDHs were studied using purified recombinant hGDH1 and hGDH2 obtained by expression of the corresponding cDNAs in Sf21 cells. Results showed that, in contrast to hGDH1 that maintains substantial basal activity (35-40% of its maximal capacity), hGDH2 displays low basal activity (3-8% of maximal) that is remarkably responsive to activation by rising levels of ADP and/or l-leucine. This is primarily due to the Arg443Ser evolutionary change, which also made hGDH2 markedly sensitive to estrogens and neuroleptic drugs. In contrast to hGDH1, which is subject to potent GTP inhibition, hGDH2 has dissociated its function from this energy switch, being able to metabolize glutamate even when the Krebs cycle generates GTP levels sufficient to inactivate the housekeeping hGDH1. Our data also show that spermidine, a polyamine thought to reduce oxidative stress and to prolong survival, and EGCG, a green tea polyphenol, inhibit hGDH2 at lower concentrations than hGDH1. The implications of these findings in nerve tissue biology are discussed.
哺乳动物谷氨酸脱氢酶(GDH)是一种看家的线粒体酶(人类中的 hGDH1),可催化谷氨酸可逆转化为α-酮戊二酸和氨,从而将氨基酸和碳水化合物代谢联系起来。它显示出一种能量感应机制,允许在细胞能量状态较低时酶激活。由于 GDH 处于重要代谢途径的交叉点,因此对其活性的严格控制至关重要。事实上,为了在代谢和细胞能量学中发挥作用,哺乳动物 GDH 已经进化成为一种高度受调节的酶,受到各种化合物的变构调节。最近在类人猿和人类中出现了一种具有独特调节特性的 hGDH2 同工酶(<2300 万年前),以及在 hGDH1 和 hGDH2 中检测到影响神经系统的功能获得变异体,这引入了更多的复杂性。通过在 Sf21 细胞中表达相应的 cDNA 获得纯化的重组 hGDH1 和 hGDH2 来研究这两种高度同源的人类 GDH 的特性。结果表明,与维持大量基础活性(其最大能力的 35-40%)的 hGDH1 相反,hGDH2 显示出低基础活性(最大活性的 3-8%),对 ADP 和/或 l-亮氨酸水平升高的激活非常敏感。这主要是由于 Arg443Ser 的进化变化,这也使 hGDH2 对雌激素和神经安定药非常敏感。与受 GTP 强烈抑制的 hGDH1 不同,hGDH2 已经将其功能与其能量开关分离,即使三羧酸循环产生足以使管家 hGDH1 失活的 GTP 水平,它也能够代谢谷氨酸。我们的数据还表明,多胺亚精胺,一种被认为可降低氧化应激并延长存活的多胺,以及绿茶多酚 EGCG,以低于 hGDH1 的浓度抑制 hGDH2。讨论了这些发现对神经组织生物学的影响。